Skip to main content
Sinopharm Tech Holdings Limited logo

Sinopharm Tech Holdings Limited — Investor Relations & Filings

Ticker · 8156 ISIN · KYG2159V1418 HKEX Wholesale and retail trade
Open in API
Filings indexed 1,471 across all filing types
Latest filing 2024-07-18 Proxy Solicitation & In…
Country HK Hong Kong
Listing HKEX 8156

About Sinopharm Tech Holdings Limited

http://www.sinopharmtech.com.hk

Sinopharm Tech Holdings Limited is an investment holding company primarily engaged in the big health industry and pharmaceutical supply chain business. The company focuses on the trading and distribution of medical and related products, including Chinese patent medicines and health products, targeting the market in the PRC. It develops its supply chain operations using "Internet Plus" services, leveraging technology to provide value-added services to industry operators and product suppliers. The Group is also integrating AI analytics to enhance its operations within the healthcare sector.

Recent filings

Filing Released Lang Actions
FORM OF PROXY
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a Form of Proxy for use by shareholders at an extraordinary general meeting (EGM) of Sinopharm Tech Holdings Limited. It includes instructions for appointing a proxy to vote on resolutions related to capital reorganization, amendments to the memorandum and articles of association, loan capitalisation agreements, and a whitewash waiver. The document is procedural and related to voting at a shareholder meeting, not a report or announcement of financial results or management changes. It is not a report itself but a proxy form for voting purposes at a meeting. This fits the category of Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings.
2024-07-18 English
(1)PROPOSED CAPITAL REORGANISATION&#x3b;(2)CONNECTED TRANSACTIONS:LOAN CAPITALISATION INVOLVING ISSUE OF ORDINARY SHARES AND CONVERTIBLE PREFERENCE SHARES UNDER CONNECTED SPECIFIC MANDATE&#x3b;(3)APPL
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a circular from Sinopharm Tech Holdings Limited concerning multiple corporate actions including a proposed capital reorganisation, connected transactions involving loan capitalisation and issuance of shares, application for a whitewash waiver, amendments to the memorandum and articles of association, and a notice of an Extraordinary General Meeting (EGM). It includes detailed definitions, letters from the board and independent committees, financial information appendices, and a notice of the EGM. The document is comprehensive and intended to inform shareholders about matters to be voted on at the EGM. This type of document is typically classified as a Proxy Solicitation & Information Statement (PSI), as it provides information to shareholders to solicit their votes on corporate actions at a general meeting. It is not merely an announcement or a report publication announcement, nor is it a full annual or interim report. Therefore, the appropriate classification is PSI with high confidence.
2024-07-18 English
NOTICE OF EXTRAORDINARY GENERAL MEETING
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a notice of an Extraordinary General Meeting (EGM) for Sinopharm Tech Holdings Limited. It includes details about the meeting date, location, and the resolutions to be considered, such as capital reduction, share subdivision, loan capitalisation agreements, and amendments to the memorandum and articles of association. The document is an announcement inviting shareholders to attend and vote at the EGM, not the actual minutes or results of the meeting. It does not contain financial statements or detailed financial analysis but focuses on corporate actions requiring shareholder approval. Therefore, this document fits the category of a meeting notice rather than a report or results announcement.
2024-07-18 English
CLOSURE OF REGISTER OF MEMBERS FOR EXTRAORDINARY GENERAL MEETING
Regulatory Filings Classification · 95% confidence The document is an announcement from Sinopharm Tech Holdings Limited regarding the closure of the register of members for an Extraordinary General Meeting (EGM). It references previous announcements about capital reorganization, loan capitalization, and mandates, and provides a timetable for the EGM and related corporate actions. The document does not contain financial statements or detailed financial analysis but serves to inform shareholders about procedural details related to the EGM and capital reorganization. It is not a full report like an Annual Report or Interim Report, nor is it a voting result declaration or a proxy solicitation. It is an announcement related to corporate actions and shareholder meeting logistics, fitting best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2024-07-11 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 JUNE 2024
Regulatory Filings Classification · 95% confidence The document is a detailed monthly return report concerning movements in securities, specifically focusing on share capital, issued shares, treasury shares, share options, and confirmations related to compliance with listing rules on The Stock Exchange of Hong Kong Limited. It includes data on share consolidations, share options, and confirmations by the company secretary. The document is structured as a regulatory submission to the exchange, reporting on share capital changes and related confirmations for the month ended 30 June 2024. It does not contain financial statements, earnings data, management discussion, or audit information. It is not an announcement of a report but a regulatory filing itself, providing detailed compliance and share capital movement information. Therefore, it fits best under the category of Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2024-07-05 English
DELAY IN DESPATCH OF CIRCULAR
Regulatory Filings Classification · 95% confidence The document is an announcement from Sinopharm Tech Holdings Limited regarding a delay in the despatch of a circular related to capital reorganisation, loan capitalisation, and other corporate actions. It references regulatory rules (GEM Listing Rules, Takeovers Code) and mentions the need for shareholder approval via an Extraordinary General Meeting (EGM). The document does not contain financial statements or detailed financial data but rather informs shareholders about the delay and the expected timeline for the circular. It is a regulatory announcement about corporate actions and procedural updates, not a full report or financial disclosure. The document length is about 5,391 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-07-05 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.